Our mission is to bring forward new medicines to improve the healthspan of people with devastating cardiovascular and neuromuscular diseases.
Joined September 2011
- Tweets 1,956
- Following 739
- Followers 1,860
- Likes 434
938 Photos and videos
Pinned Tweet
Today we announced topline results from ACACIA-HCM, our Phase 3 clinical trial in non-obstructive HCM. Learn more in our press release: bit.ly/4wc5YBe
#Biopharma #HCM
5
10
1,089
May 18
New research in @JAMA_current! As a supporter of the #HCM registry, we are excited for these findings on improving risk prediction of adverse events in HCM patients.
Read more: bit.ly/42wbzF1
#CardioX
2
3
354
May 14
We had an incredible time at #HeartFailure2026!
It was a privilege to connect with leading experts, clinicians, and advocates from around the world. We are proud to be growing our European team to further support this vital community that continues to inspire our mission.
1
3
127
May 10
Attending #HeartFailure2026 in #Barcelona? Visit us at the Cytokinetics booth to talk with our team and learn more about our research & science.
We'll be presenting data, sharing abstracts, and leading a sponsored satellite symposium.
#HeartFailure #CardioX
1
4
187
$CYTK: Today, we reported our first quarter 2026 financial results. Our senior management team will provide more details in a conference call at 4:30 p.m. ET. bit.ly/4naZnCZ
#earnings
4
355
Our 3rd annual CLIMB Research Symposium is just around the corner! Taking place on May 29 in San Francisco. CLIMB brings together the scientific community to share innovative research in the field of muscle biology.
Register today: ClimbSymposium.com
#CLIMB26
164
We'll be sharing nine presentations, including a late-breaking science oral presentation, at #HeartFailure2026 in Barcelona, Spain, May 9 – 12.
Learn more: bit.ly/3PgKQJk
#HeartFailure #CardioTwitter
1
170
Apr 30
We’re looking forward to attending HFA Heart Failure 2026 in Barcelona, Spain, May 9 – 12. We'll be sharing abstracts, sponsoring a satellite symposium, and connecting with attendees at our booth.
Learn more: bit.ly/48xWKFj
#HeartFailure2026 #HeartFailure
1
166
Apr 28
Years of R&D rigor, operational planning and readiness, and thoughtful fiscal management aligned at the right time to enable fulfillment of our longstanding mission.
Read more about our progress in our 2025 annual reports: bit.ly/4vVUWjt
2
151
We're excited to be attending several clinical conferences, where we’ll be connecting with experts dedicated to advancing cardiovascular care.
#CVN2026 #AAHFN2026 #ASE2026 #CardioTwitter
2
150
We’re here at the 92nd Annual Meeting of the German Society of Cardiology (DGK) in Mannheim, Germany. Visit us at booth 113 to meet our team and learn more about our research & science.
#DGK #DGKJahrestagung #DGK2026JT #HCM #CardioTwitter
1
163
Registration is now open for our CLIMB Research Symposium taking place on May 29 in San Francisco. Hear from speakers ranging from Cytokinetics co-founder James A. Spudich, PhD, to up-and-coming researchers covering muscle biology and more. ClimbSymposium.com #CLIMB26
2
157
Mar 30
We are thrilled to be on the ground at #ACC26 this weekend, and the energy is incredible. But the real excitement? Sharing that our first approved medicine is now available for patients.
Please see full Prescribing Information, including Boxed WARNING: bit.ly/4dAIq2f
3
328
Mar 27
We’re excited to be attending #ACC26 in New Orleans, March 28 – 30. Visit us at booth #2237 to learn more about our research & science.
We’ll also be presenting new data from our clinical research programs and hosting an industry product theater.
#HCM #CardioTwitter
2
1
186
Mar 10
Join us for our CLIMB Symposium on May 29 in San Francisco!
CLIMB brings together the scientific community to share innovative research in the field of muscle biology aimed at driving advancements.
Register today: ClimbSymposium.com.
#CLIMB26
1
4
300
Feb 24
$CYTK: Today, we reported our fourth quarter 2025 financial results. Our senior management team will provide more details in a conference call at 4:30 p.m. ET.
bit.ly/4ryyFp4
4
587
Jan 12
Our new medicine for the treatment of adults with symptomatic oHCM is now FDA-approved. This approval is the result of years of clinical research and collaboration with the HCM community, and most importantly, marks progress for patients.
#HCM #CardioTwitter
1
3
642
$CYTK: We'll be presenting at the annual #JPM25 in San Francisco on January 12.
We're looking forward to sharing what's next as we continue to advance our mission to meaningfully improve the lives of patients with diseases of impaired muscle function. bit.ly/49Ln5Q7
7
742
19 Dec 2025
Today’s @US_FDA announcement is a significant milestone for Cytokinetics. Thank you to the patients, families, investigators, and advocates who helped make this moment possible.
#TeamCyto #Biopharma
1
3
15
2,984